-
- 抗原 See all CD19 抗体
- CD19 (CD19 Molecule (CD19))
-
适用
- 人
- 宿主
- 请咨询
-
克隆类型
- 单克隆
-
标记
- This CD19 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- 特异性
- Ni-NTA purified recombinant human CD19 expressed in E. Coli strain M15.
- 纯化方法
- Antibodies are purified by protein A affinity chromatography
- 亚型
- IgG2a
- Top Product
- Discover our top product CD19 Primary Antibody
-
-
- 应用备注
-
Western Blot: Dilution 1: 2000- 5,000
IHC(P): Dilution 1: 100- 1: 400
IHC(F): Dilution 1: 200- 1: 400
ELISA: Propose dilution 1: 10,000.
Determining optimal working dilutions by titration test.
Determining optimal working dilutions by titration test. - 限制
- 仅限研究用
-
- 储存条件
- -20 °C
-
-
Inhibition, by vinca alkaloids and colchicine, of antigenic modulation induced by anti-CD19 monoclonal antibodies." in: Leukemia research, Vol. 12, Issue 2, pp. 135-41, (1988) (PubMed).
: "Evaluation of a method of production and purification of monoclonal antibodies for clinical applications." in: Journal of immunological methods, Vol. 102, Issue 2, pp. 187-93, (1987) (PubMed).
: "
-
Inhibition, by vinca alkaloids and colchicine, of antigenic modulation induced by anti-CD19 monoclonal antibodies." in: Leukemia research, Vol. 12, Issue 2, pp. 135-41, (1988) (PubMed).
-
- 抗原
- CD19 (CD19 Molecule (CD19))
- 别名
- CD19 (CD19 产品)
- 别名
- B4 antibody, CVID3 antibody, AW495831 antibody, CD19 antibody, CD19 molecule antibody, CD19 antigen antibody, CD19 antibody, Cd19 antibody
- 背景
- The CD19 antigen (95kDa) is expressed from the earliest stage of B progenitor development, on all peripheral B cells including germinal centre B cells, and all B cell lines and B cell leukaemia tested. T cell and monocytic cell lines are negative and the antigen is lost on B cell maturation to plasma cells. The antigen is a type I integral membrane glycoprotein whose in vitro inhibition will influence B cell activation and proliferation.
- 基因ID
- 930
- 途径
- Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
-